Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2025Journal of the Medical Association of Thailand

Prevalence of Anxiety in Post-Treatment Ovarian Cancer Survivors

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Descriptive study assesses anxiety prevalence at 10.7% among ovarian cancer survivors, highlighting TAT relevance and support needs.

Key Points

  • The prevalence of anxiety was found to be 10.7% among ovarian cancer survivors, indicating a significant concern.
  • Younger ovarian cancer survivors reported higher anxiety levels, averaging 45.4 years compared to 56.8 years without anxiety.
  • Assessment was conducted using the Hospital Anxiety and Depression Scale, capturing demographic and clinical data.
  • Early psychological support for ovarian cancer survivors is crucial, especially during the initial months post-treatment.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/68a35ee30a429f79733278bahttps://doi.org/10.35755/jmedassocthai.2025.7.574-579-02930
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 11335 Depression and anxiety among women treated for cervical cancer2024 · 3 citations
  2. 2Anxiety and Depression are Common in Surgical Oncology Patients: Results of a Prospective Cohort Study2024
  3. 3Social support, anxiety and depression after chemotherapy for ovarian cancer: A prospective study2004 · 171 citations
  4. 4Psychological adjustment differences in ovarian cancer patients receiving different treatment modalities and their clinical significance2025
  5. 5Psychological characteristics of Japanese gynecologic cancer patients after learning the diagnosis according to the hospital anxiety and depression scale2011 · 38 citations